Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants.

Autor: Rothenberger S; Spiez Laboratory, Austrasse, Spiez, Switzerland.; Institute of Microbiology, University Hospital Center and University of Lausanne, Lausanne, Switzerland., Hurdiss DL; Department Biomolecular Health Sciences, Division Infectious Diseases & Immunology - Virology section, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands.; Cryo-Electron Microscopy, Bijvoet Center for Biomolecular Research, Department of Chemistry, Faculty of Science, Utrecht University, Utrecht, Netherlands., Walser M; Molecular Partners AG, Zurich-Schlieren, Switzerland., Malvezzi F; Molecular Partners AG, Zurich-Schlieren, Switzerland., Mayor J; Spiez Laboratory, Austrasse, Spiez, Switzerland.; Institute of Microbiology, University Hospital Center and University of Lausanne, Lausanne, Switzerland., Ryter S; Spiez Laboratory, Austrasse, Spiez, Switzerland., Moreno H; Institute of Microbiology, University Hospital Center and University of Lausanne, Lausanne, Switzerland., Liechti N; Spiez Laboratory, Austrasse, Spiez, Switzerland., Bosshart A; Molecular Partners AG, Zurich-Schlieren, Switzerland., Iss C; Molecular Partners AG, Zurich-Schlieren, Switzerland., Calabro V; Molecular Partners AG, Zurich-Schlieren, Switzerland., Cornelius A; Molecular Partners AG, Zurich-Schlieren, Switzerland., Hospodarsch T; Molecular Partners AG, Zurich-Schlieren, Switzerland., Neculcea A; Molecular Partners AG, Zurich-Schlieren, Switzerland., Looser T; Molecular Partners AG, Zurich-Schlieren, Switzerland., Schlegel A; Molecular Partners AG, Zurich-Schlieren, Switzerland., Fontaine S; Molecular Partners AG, Zurich-Schlieren, Switzerland., Villemagne D; Molecular Partners AG, Zurich-Schlieren, Switzerland., Paladino M; Molecular Partners AG, Zurich-Schlieren, Switzerland., Schiegg D; Molecular Partners AG, Zurich-Schlieren, Switzerland., Mangold S; Molecular Partners AG, Zurich-Schlieren, Switzerland., Reichen C; Molecular Partners AG, Zurich-Schlieren, Switzerland., Radom F; Molecular Partners AG, Zurich-Schlieren, Switzerland., Kaufmann Y; Molecular Partners AG, Zurich-Schlieren, Switzerland., Schaible D; Molecular Partners AG, Zurich-Schlieren, Switzerland., Schlegel I; Molecular Partners AG, Zurich-Schlieren, Switzerland., Zitt C; Molecular Partners AG, Zurich-Schlieren, Switzerland., Sigrist G; Molecular Partners AG, Zurich-Schlieren, Switzerland., Straumann M; Molecular Partners AG, Zurich-Schlieren, Switzerland., Wolter J; Molecular Partners AG, Zurich-Schlieren, Switzerland., Comby M; Molecular Partners AG, Zurich-Schlieren, Switzerland., Sacarcelik F; Molecular Partners AG, Zurich-Schlieren, Switzerland., Drulyte I; Materials and Structural Analysis, Thermo Fisher Scientific, Eindhoven, Netherlands., Lyoo H; Department Biomolecular Health Sciences, Division Infectious Diseases & Immunology - Virology section, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands., Wang C; Department Biomolecular Health Sciences, Division Infectious Diseases & Immunology - Virology section, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands., Li W; Department Biomolecular Health Sciences, Division Infectious Diseases & Immunology - Virology section, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands., Du W; Department Biomolecular Health Sciences, Division Infectious Diseases & Immunology - Virology section, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands., Binz HK; Binz Biotech Consulting, Zug, Switzerland., Herrup R; Laboratory of Immunoregulation, Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Lusvarghi S; Laboratory of Immunoregulation, Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Neerukonda SN; Laboratory of Immunoregulation, Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Vassell R; Laboratory of Immunoregulation, Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Wang W; Laboratory of Immunoregulation, Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Adler JM; Freie Universität Berlin, Institut für Virologie, Berlin, Germany., Eschke K; Freie Universität Berlin, Institut für Virologie, Berlin, Germany., Nascimento M; Freie Universität Berlin, Institut für Virologie, Berlin, Germany., Abdelgawad A; Freie Universität Berlin, Institut für Virologie, Berlin, Germany., Gruber AD; Freie Universität Berlin, Institut für Tierpathologie, Berlin, Germany., Bushe J; Freie Universität Berlin, Institut für Tierpathologie, Berlin, Germany., Kershaw O; Freie Universität Berlin, Institut für Tierpathologie, Berlin, Germany., Knutson CG; Novartis Institutes for BioMedical Research, PK Sciences, Cambridge, MA, USA., Balavenkatraman KK; Novartis Institutes for BioMedical Research, Preclinical Safety, Basel, Switzerland., Ramanathan K; Novartis Pharma AG, Basel, Switzerland., Wyler E; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Teixeira Alves LG; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Lewis S; Molecular Partners AG, Zurich-Schlieren, Switzerland., Watson R; Molecular Partners AG, Zurich-Schlieren, Switzerland., Haeuptle MA; Molecular Partners AG, Zurich-Schlieren, Switzerland., Zürcher A; Molecular Partners AG, Zurich-Schlieren, Switzerland., Dawson KM; Molecular Partners AG, Zurich-Schlieren, Switzerland., Steiner D; Molecular Partners AG, Zurich-Schlieren, Switzerland., Weiss CD; Laboratory of Immunoregulation, Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Amstutz P; Molecular Partners AG, Zurich-Schlieren, Switzerland., van Kuppeveld FJM; Department Biomolecular Health Sciences, Division Infectious Diseases & Immunology - Virology section, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands., Stumpp MT; Molecular Partners AG, Zurich-Schlieren, Switzerland. info@molecularpartners.com., Bosch BJ; Department Biomolecular Health Sciences, Division Infectious Diseases & Immunology - Virology section, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands., Engler O; Spiez Laboratory, Austrasse, Spiez, Switzerland., Trimpert J; Freie Universität Berlin, Institut für Virologie, Berlin, Germany.

Publikováno v: Nature biotechnology [Nat Biotechnol] 2022 Dec; Vol. 40 (12), pp. 1845-1854. Date of Electronic Publication: 2022 Jul 21.

Le Web de demain raconté au CERN par son inventeur

Autor: Sigrist, G

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od________65::71aea7582c05644be45cb71b280959a4
http://cds.cern.ch/record/718658

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Membrane effects of chloride substitutes in guinea pig gallbladder epithelial cells.

Autor: WEHNER, F., SIGRIST, G., PETERSEN, K.-U.

Publikováno v: American Journal of Physiology: Cell Physiology; Oct1989, Vol. 257 Issue 4, pC766-C774, 9p